These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 17928361)
41. Ecto-ADP-ribosyltransferase ARTC2.1 functionally modulates FcγR1 and FcγR2B on murine microglia. Rissiek B; Menzel S; Leutert M; Cordes M; Behr S; Jank L; Ludewig P; Gelderblom M; Rissiek A; Adriouch S; Haag F; Hottiger MO; Koch-Nolte F; Magnus T Sci Rep; 2017 Nov; 7(1):16477. PubMed ID: 29184112 [TBL] [Abstract][Full Text] [Related]
42. A Methodological Approach Using rAAV Vectors Encoding Nanobody-Based Biologics to Evaluate ARTC2.2 and P2X7 Gondé H; Demeules M; Hardet R; Scarpitta A; Junge M; Pinto-Espinoza C; Varin R; Koch-Nolte F; Boyer O; Adriouch S Front Immunol; 2021; 12():704408. PubMed ID: 34489954 [TBL] [Abstract][Full Text] [Related]
43. P2X7 on Mouse T Cells: One Channel, Many Functions. Rissiek B; Haag F; Boyer O; Koch-Nolte F; Adriouch S Front Immunol; 2015; 6():204. PubMed ID: 26042119 [TBL] [Abstract][Full Text] [Related]
44. Basal and inducible expression of the thiol-sensitive ART2.1 ecto-ADP-ribosyltransferase in myeloid and lymphoid leukocytes. Hong S; Brass A; Seman M; Haag F; Koch-Nolte F; Dubyak GR Purinergic Signal; 2009 Sep; 5(3):369-83. PubMed ID: 19404775 [TBL] [Abstract][Full Text] [Related]
45. Discovery of ligands for ADP-ribosyltransferases via docking-based virtual screening. Andersson CD; Karlberg T; Ekblad T; Lindgren AE; Thorsell AG; Spjut S; Uciechowska U; Niemiec MS; Wittung-Stafshede P; Weigelt J; Elofsson M; Schüler H; Linusson A J Med Chem; 2012 Sep; 55(17):7706-18. PubMed ID: 22823910 [TBL] [Abstract][Full Text] [Related]
46. The P2X7 Receptor. Sluyter R Adv Exp Med Biol; 2017; 1051():17-53. PubMed ID: 28676924 [TBL] [Abstract][Full Text] [Related]
47. Generation and characterization of ecto-ADP-ribosyltransferase ART2.1/ART2.2-deficient mice. Ohlrogge W; Haag F; Löhler J; Seman M; Littman DR; Killeen N; Koch-Nolte F Mol Cell Biol; 2002 Nov; 22(21):7535-42. PubMed ID: 12370300 [TBL] [Abstract][Full Text] [Related]
53. Extracellular NAD and ATP: Partners in immune cell modulation. Haag F; Adriouch S; Braß A; Jung C; Möller S; Scheuplein F; Bannas P; Seman M; Koch-Nolte F Purinergic Signal; 2007 Mar; 3(1-2):71-81. PubMed ID: 18404420 [TBL] [Abstract][Full Text] [Related]
54. Astrocytes and Microglia Are Resistant to NAD Rissiek B; Stabernack J; Cordes M; Duan Y; Behr S; Menzel S; Magnus T; Koch-Nolte F Front Mol Neurosci; 2019; 12():330. PubMed ID: 32009900 [TBL] [Abstract][Full Text] [Related]
55. Structural and Functional Consequences Induced by Post-Translational Modifications in α-Defensins. Balducci E; Bonucci A; Picchianti M; Pogni R; Talluri E Int J Pept; 2011; 2011():594723. PubMed ID: 21904558 [TBL] [Abstract][Full Text] [Related]
56. A novel predicted ADP-ribosyltransferase-like family conserved in eukaryotic evolution. Wyżewski Z; Gradowski M; Krysińska M; Dudkiewicz M; Pawłowski K PeerJ; 2021; 9():e11051. PubMed ID: 33854844 [TBL] [Abstract][Full Text] [Related]
58. ADP-ribosylation of P2X7: a matter of life and death for regulatory T cells and natural killer T cells. Rissiek B; Haag F; Boyer O; Koch-Nolte F; Adriouch S Curr Top Microbiol Immunol; 2015; 384():107-26. PubMed ID: 25048544 [TBL] [Abstract][Full Text] [Related]
59. Unlocking the therapeutic potential of P2X7 receptor: a comprehensive review of its role in neurodegenerative disorders. Liu X; Li Y; Huang L; Kuang Y; Wu X; Ma X; Zhao B; Lan J Front Pharmacol; 2024; 15():1450704. PubMed ID: 39139642 [TBL] [Abstract][Full Text] [Related]